Rici Healthcare Holdings Ltd. (1526) AI Stock Analysis

• Market Cap: HK$1.59B
• Dividend Yield: 4.5%
• Average Volume (3M): 164.22K
• Price to Earnings (P/E): 5.5
• Beta (1Y): 0.29
• Revenue Growth: -3.56%
• EPS Growth: -17.45%
• Country: HK
• Employees: 8,908
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 0.04
• Shares Outstanding: 1,590,324,000
• 10 Day Avg. Volume: 222,410
• 30 Day Avg. Volume: 164,220
• PEG Ratio: -0.36
• Price to Book (P/B): 1.39
• Price to Sales (P/S): 0.64
• P/FCF Ratio: 3.20
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 66 Neutral
• Price Target: HK$1.00 ▲(1.01% Upside)

Rici Healthcare Holdings Ltd. scores well on valuation due to its low P/E ratio and attractive dividend yield, making it appealing for value and income investors. However, financial performance is mixed, with strong profitability offset by revenue decline and high leverage. Technical indicators suggest a bearish trend, which could limit short-term upside potential.

Rici Healthcare Holdings Ltd. Business Overview & Revenue Model

Company Description

Rici Healthcare Holdings Ltd. (1526) is a leading provider of comprehensive medical and healthcare services in China. The company operates through three main segments: medical examination services, hospital services, and medical consultancy services. Rici Healthcare is dedicated to delivering high-quality healthcare solutions, focusing on preventive care, diagnostic services, and treatment through its network of medical examination centers and hospitals.

How the Company Makes Money

Rici Healthcare Holdings Ltd. generates revenue primarily through its medical examination services, hospital services, and medical consultancy services. The company earns income from providing routine health check-ups, specialized medical tests, and diagnostic services through its medical examination centers. Hospital services contribute to the revenue by offering inpatient and outpatient care, surgical procedures, and specialized medical treatments. Additionally, Rici Healthcare offers medical consultancy services, providing expert guidance and management solutions to other healthcare institutions. Key partnerships with insurance providers and corporate clients also play a significant role in driving revenue, as they bring in a steady flow of patients seeking preventive and diagnostic healthcare services.

Rici Healthcare Holdings Ltd. Financial Statement Overview

Summary

Rici Healthcare Holdings Ltd. demonstrates strong profitability with solid profit margins and return on equity. However, the decline in revenue growth and high leverage pose potential risks. Cash flow management is a critical area for improvement, as recent metrics indicate challenges in maintaining liquidity.

Income Statement

Rici Healthcare Holdings Ltd. shows a strong gross profit margin of 39.9% and a net profit margin of 10.2% for the latest year. Revenue showed a slight decline of 2.3% compared to the previous year, indicating some challenges in maintaining growth. The EBIT margin is healthy at 20.8%, and the EBITDA margin stands at 27.3%, reflecting solid operational efficiency. While profitability remains robust, the recent revenue contraction highlights the need for strategic growth initiatives.

Balance Sheet

The company's debt-to-equity ratio is relatively high at 1.71, indicating leverage that could pose risks if not managed carefully. However, the return on equity is strong at 22.1%, showing effective use of equity capital. With an equity ratio of 27.7%, the company maintains a balanced asset structure, though the high debt level suggests potential volatility in financial stability.

Cash Flow

Rici Healthcare's free cash flow is currently zero, which poses concerns about liquidity and operational cash coverage. The previous year showed a positive operating cash flow to net income ratio of 2.27, indicating healthy cash generation relative to net income in the past. The absence of free cash flow growth in the latest year suggests cash flow management may need attention to sustain operations and fund growth.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.27B	2.92B	2.99B	2.38B	2.38B	1.93B
Gross Profit	975.27M	1.17B	1.25B	927.20M	975.22M	580.66M
EBITDA	651.40M	798.69M	1.07B	572.61M	682.80M	234.75M
Net Income	240.30M	297.32M	363.80M	290.79M	181.55M	-7.88M
Balance Sheet
Total Assets	4.72B	4.86B	4.64B	4.57B	4.54B	4.21B
Cash, Cash Equivalents and Short-Term Investments	1.03B	1.12B	811.21M	720.14M	784.36M	574.86M
Total Debt	2.25B	2.30B	2.27B	2.30B	2.74B	2.90B
Total Liabilities	3.30B	3.48B	3.52B	3.66B	3.95B	3.88B
Stockholders Equity	1.40B	1.35B	1.13B	953.92M	677.50M	505.81M
Cash Flow
Free Cash Flow	311.65M	584.35M	487.07M	396.33M	356.41M	77.71M
Operating Cash Flow	358.39M	790.58M	826.29M	706.37M	681.07M	444.63M
Investing Cash Flow	-15.50M	-140.02M	-147.00M	-273.99M	-269.13M	-355.44M
Financing Cash Flow	-81.44M	-351.23M	-592.72M	-495.23M	-193.99M	169.32M

Rici Healthcare Holdings Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.99
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1526, the sentiment is Positive. The current price of 0.99 is below the 20-day moving average (MA) of 1.01, below the 50-day MA of 1.02, and below the 200-day MA of 1.10, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 50.78 is Neutral, neither overbought nor oversold. The STOCH value of 28.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1526.

Rici Healthcare Holdings Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3689	71 Outperform	HK$635.35M	7.70	5.33%	8.42%	0.47%	50.46%
1526	66 Neutral	HK$1.59B	5.48	20.47%	4.50%	-3.56%	-17.45%
9906	57 Neutral	HK$966.00M	78.16	1.87%	―	-13.22%	-69.35%
3869	56 Neutral	HK$827.78M	5.69	30.40%	―	2.30%	―
1419	55 Neutral	HK$311.23M	11.82	3.40%	3.41%	9.07%	8.95%
3886	52 Neutral	HK$1.86B	-12.97	-4.66%	0.46%	-0.55%	45.36%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Rici Healthcare Holdings Ltd. Corporate Events

Rici Healthcare Reports Decline in Interim Revenue and Profit

Rici Healthcare Holdings Ltd. announced its interim financial results for the six months ending June 30, 2025, revealing a 7% decrease in revenue compared to the same period in 2024. Despite a slight increase in gross profit, the company’s profit attributable to owners fell significantly, and the adjusted EBITDA also saw a decline. The board decided not to declare any interim dividend for the reporting period, indicating a cautious approach amid financial challenges.

The most recent analyst rating on (HK:1526) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Rici Healthcare Holdings Ltd. stock, see the HK:1526 Stock Forecast page.

Rici Healthcare Schedules Board Meeting for Interim Results

Rici Healthcare Holdings Ltd. has announced a board meeting scheduled for August 28, 2025, to discuss and approve the interim results for the first half of 2025 and consider the payment of an interim dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.